We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 63.00 | 61.00 | 65.00 | 63.00 | 63.00 | 63.00 | 14,893 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -4.80 | 14.85M |
From Apr 2019 to Apr 2024
TIDMNSCI
RNS Number : 1237A
NetScientific PLC
24 May 2019
NetScientific plc
("NetScientific" or the "Company" or the "Group")
Notice of AGM and Annual Report & Accounts
London, UK - 24 May 2019 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that, in accordance with AIM Rules 20 and 26, the Group's Annual Report and Accounts for the year ended 31 December 2018 and Notice of Annual General Meeting have been sent to shareholders today and are available on the Company's website in the Investor Relations section at http://www.netscientific.net/investors.
The Annual General Meeting of the Group will be held on Tuesday, 18 June 2019 at 12.00 p.m. at Ashurst LLP, 1 Duval Square, London Fruit and Wool Exchange, London E1 6PW, United Kingdom.
# # #
For more information, please contact:
Hot Features
Premium
NetScientific Tel: +44 (0)20 3514 1800
Ian Postlethwaite, CEO
Tel: +44 (0)20 7220
WHIreland (NOMAD, Financial Adviser and 1666
Broker)
Chris Fielding / Jessica Cave
About NetScientific
NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people.
For more information, please visit the website at www.NetScientific.net
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ACSEAPSLALSNEEF
(END) Dow Jones Newswires
May 24, 2019 04:50 ET (08:50 GMT)
1 Year Netscientific Chart |
1 Month Netscientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
